| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,762 |
3,999 |
$212K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,112 |
8,326 |
$197K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
411 |
356 |
$52K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,469 |
1,381 |
$41K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,309 |
1,211 |
$41K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,444 |
1,373 |
$38K |
| 0002A |
|
978 |
844 |
$33K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
625 |
581 |
$32K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
783 |
705 |
$27K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
812 |
757 |
$20K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
187 |
164 |
$14K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
354 |
331 |
$13K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
287 |
273 |
$12K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
112 |
80 |
$12K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,163 |
3,921 |
$11K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
119 |
109 |
$11K |
| 0001A |
|
465 |
441 |
$10K |
| 44361 |
|
118 |
95 |
$7K |
| 93000 |
|
340 |
290 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
128 |
106 |
$3K |
| 0071A |
|
66 |
62 |
$2K |
| 0072A |
|
63 |
62 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
412 |
381 |
$2K |
| 93351 |
|
12 |
12 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
71 |
67 |
$870.17 |
| 99383 |
|
26 |
25 |
$847.53 |
| 99215 |
Prolong outpt/office vis |
14 |
13 |
$790.60 |
| 90461 |
|
1,792 |
1,670 |
$740.68 |
| 99201 |
|
26 |
24 |
$659.69 |
| 90677 |
|
168 |
139 |
$586.94 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
13 |
13 |
$432.14 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
70 |
33 |
$394.46 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
846 |
810 |
$340.20 |
| 96127 |
|
653 |
624 |
$297.16 |
| 90686 |
|
1,623 |
1,526 |
$119.83 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
127 |
115 |
$80.63 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
19 |
15 |
$80.21 |
| 81003 |
|
47 |
38 |
$58.99 |
| 90670 |
|
832 |
774 |
$8.02 |
| 90698 |
|
755 |
693 |
$4.03 |
| 90680 |
|
619 |
568 |
$4.02 |
| 90744 |
|
215 |
200 |
$4.01 |
| 3074F |
|
1,831 |
1,428 |
$0.76 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
535 |
476 |
$0.60 |
| 3078F |
|
1,549 |
1,183 |
$0.53 |
| 3079F |
|
407 |
291 |
$0.28 |
| 3077F |
|
335 |
185 |
$0.13 |
| 3075F |
|
66 |
48 |
$0.05 |
| 1160F |
|
612 |
540 |
$0.05 |
| 90656 |
|
231 |
226 |
$0.03 |
| 3080F |
|
44 |
26 |
$0.02 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
272 |
186 |
$0.01 |
| 90651 |
|
224 |
209 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
793 |
671 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
955 |
897 |
$0.00 |
| 90716 |
|
113 |
109 |
$0.00 |
| G9273 |
Blood pressure has a systolic value of < 140 and a diastolic value of < 90 |
344 |
313 |
$0.00 |
| 1111F |
|
63 |
56 |
$0.00 |
| 91307 |
|
173 |
158 |
$0.00 |
| 90688 |
|
23 |
20 |
$0.00 |
| 90620 |
|
12 |
12 |
$0.00 |
| 1000F |
|
16 |
12 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
2,729 |
1,714 |
$0.00 |
| 90633 |
|
168 |
159 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
54 |
51 |
$0.00 |
| 90671 |
|
63 |
58 |
$0.00 |
| 90707 |
|
113 |
109 |
$0.00 |
| 90734 |
|
51 |
48 |
$0.00 |
| 90658 |
|
63 |
60 |
$0.00 |
| 91300 |
|
23 |
13 |
$0.00 |
| 0502F |
|
30 |
15 |
$0.00 |
| 90715 |
|
12 |
12 |
$0.00 |